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Abstract
Background: Granular cell tumors (GCTs) are extremely rare lesions of the urinary bladder with
only nine cases being reported in world literature of which one was malignant. Generally believed
to be of neural origin based on histochemical, immunohistochemical, and ultrastructural studies;
they mostly follow a clinically benign course but are commonly mistaken for malignant tumors since
they are solid looking, ulcerated tumors with ill-defined margins.
Materials and methods: We herein report two cases of GCTs, one benign and one malignant,
presenting with gross hematuria in a 14- and a 47-year-old female, respectively.
Results: Histopathology revealed characteristic GCTs with positive immunostaining for neural
marker (S-100) and negative immunostaining for epithelial (cytokeratin, Cam 5.2, AE/A13),
neuroendocrine (neuron specific enolase, chromogranin A, and synaptophysin) and sarcoma
(desmin, vimentin) markers. The benign tumor was successfully managed conservatively with
transurethral resection alone while for the malignant tumor, radical cystectomy, hysterectomy with
bilateral salpingo-oophorectomy, anterior vaginectomy, plus lymph node dissection was done. Both
cases show long-term disease free survival.
Conclusion: We recommend careful pathologic assessment for establishing the appropriate
diagnosis and either a conservative or aggressive surgical treatment for benign or localized
malignant GCT of the urinary bladder, respectively.

Background
Granular cell tumors are unusual, rare neoplasm that
most commonly affect the head and neck region, especially the tongue. Only nine cases of granular cell tumors
of the urinary bladder have thus far been reported.
Although usually benign, these lesions may present as
solid tumors with ill-defined margins and ulcerated surface, masquerading as a malignant tumor at initial presentation, and hence could be confused with transitional cell/

squamous cell carcinoma or sarcoma in the urinary bladder. Only one case of malignant granular cell tumor of the
urinary bladder has thus far been reported. We herein,
report two cases of granular cell tumor of the urinary bladder, one benign and one malignant, and review the literature with a view to comment on the existing experience
about the presentation, diagnosis and management of
this rare bladder tumor.
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Case presentations
Case-1
A 14-year-old girl presented to the Emergency Room in
December 1999 with her first episode of severe gross,
painless hematuria. Past history was unremarkable. On
examination she was pale, dehydrated and continually
bleeding per urethram. Heart rate was 120/minute, blood
pressure 90/55 mmHg and she was afebrile. Hemoglobin
was 5.9 gm/dl, hematocrit 18 with coagulation profile
and routine chemistry being normal. Urinalysis showed
large amounts of RBC's and 08 WBC's/HPF. Urine culture
and sensitivity was later negative for bacterial growth. At
emergency cystoscopy following resuscitation, she was
found to have an 8 × 10 cm highly vascular, solid, infiltrative tumor occupying the right lateral wall and ipsilateral
half of the trigone. The tumor involved the right ureteric
orifice and extended to 1 cm short of the bladder neck.
Preoperative intravenous pyelogram showed a non-excretory right kidney due to hydronephrosis with normal contralateral system. Transurethral resection of the tumor till
bladder wall level was done. She needed 5 units of packed
cells transfusion. Subsequently, right percutaneous nephrostomy was done, which was later internalized with a
double J stent.
Pathologic findings
Microscopic examination of the tissue revealed cohesive
groups of cells arranged in lobules by dividing fibrous septae. There was no evidence of muscle invasion. The cells
contained abundant granular eosinophilic cytoplasm
with round monomorphic nuclei and showed focal positivity with PAS stain (Figure 1a &1b). Immunohistochemical studies revealed diffuse positivity with S-100 protein,
and negativity with Desmin and Vimentin, thus consistent
with granular cell tumor instead of the suspected sarcoma.
Positivity with neuron specific enolase, chromogranin
and synaptophysin was not seen and S-100 staining was
seen in tumor cells and not in sustentacular cells as noted
in pheochromocytoma
Course
CT scan of the abdomen/pelvis and chest X-ray showed no
metastases. There was localized thickening of the bladder
wall with no extravesical extension. At repeat cystoscopy 2
weeks later, there was no obvious residual tumor and
deep biopsies from previous resection site were clear.
Hence, it was decided to treat the patient conservatively.
Follow-up CT scan of the abdomen/pelvis 4 months later
showed a normal-looking bladder (Figure 2). Cystoscopy
with multiple bladder biopsies was again negative for
tumor recurrence and only showed acute on chronic
inflammation. The double J stent was removed. Follow up
IVP at 12 months was normal. She now remains free of
disease at over 4 years since the operation.

Figure
(a):
patient
Histology
11(haematoxylin
of benign and
granular
eosincell
stain
tumor
×100)
of the bladder of
(a): Histology of benign granular cell tumor of the bladder of
patient 1 (haematoxylin and eosin stain ×100); b): Histology
of benign granular cell tumor of the bladder of patient1 (haematoxylin and eosin stain ×100); c): Immunohistochemical
staining of benign granular cell tumor of the bladder of
patient 1. (S-100 stain) Note positive staining of cell nucleus
and cytoplasm. (×100).

Case-2
A 47-year-old lady, married with 6 children, diabetic and
hypertensive, presented to the urology clinic in July 1995
with gross intermittent hematuria and dysuria for one
year. She also complained of urgency and urge incontinence. About 25 years back, she had a laparotomy for
intestinal obstruction secondary to tuberculosis and had
received a one year course of antituberculous medical
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Figure
CT scan2of the abdomen/pelvis at 4 months post op showing a normal-looking bladder with right double J stent in place
CT scan of the abdomen/pelvis at 4 months post op showing a normal-looking bladder with right double J stent in place.

therapy. Physical examination was unremarkable except
for some fullness in the left lower quadrant of abdomen.
Hemoglobin was 8.5 gm/dl, hematocrit 26.2 (normal =
35.4 – 42.8%) with coagulation profile and routine chemistry being normal. Urinanalysis showed hematuria and
pyuria while urine culture was negative for bacterial
growth. Ultrasound revealed a 2.6 × 1.8 cm polypoidal
mass in the left posterior wall of urinary bladder with
bladder wall irregularity. An IVP showed normal upper
urinary tracts with a filling defect in the bladder.
Cystoscopy revealed an approximately 4 × 3 × 3 cm solid
tumor in the left postero-lateral wall, above the ureteric
orifice. Multiple biopsies of the tumor from the base and
edges, as well as random bladder biopsies, were obtained.

Pathologic findings
The tumor was arranged in large clusters with diffuse
sheets invading and insinuating in between the smooth
muscle fibers. The tumor cells exhibited pleomorphism,
nuclear hyperchromasia, with 2–3 mitoses/10 HPF (Figure 3a &3b). Random bladder biopsies were normal.
Immunohistochemical studies showed the tumor cells to
be S-100 positive and cytokeratin Cam 5.2, AE/A13 negative, illustrating a non-epithelial origin. The pathologic
diagnosis of a muscle-invasive, malignant granular cell
tumor of the urinary bladder was made. Neuroendocrine
markers such as neuron specific enolase, chromogranin,
synaptophysin were negative.
Course
A radionuclide bone scan was negative for metastasis. A
CT scan of abdomen and pelvis showed no extravesical
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(a):
Figure
Histology
3
of malignant granular cell tumor of the bladder of patient 2 (haematoxylin and eosin stain)
(a): Histology of malignant granular cell tumor of the bladder of patient 2 (haematoxylin and eosin stain). Note infiltration of
tumor cells into the smooth muscle. (×100); b): Histology of malignant granular cell tumor of the bladder of patient 2 (haematoxylin and eosin stain). The cells exhibit abundant pink granular cytoplasm. Note prominent nucleoli in majority of cells.
(×100);
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Table 1: Summary of Granular cell tumor of the urinary bladder cases
References

Age/Sex

Histologic Diagnosis

Surgery

Recurrence

Follow up

Ravich et al, 1945[1]

31 y/M

MGCT

Complete Excision

Yes

61 y/M

BGCT

No

Seery, 1968[3]
Okuda et al, 1969[4]
Christ and Ozzello, 1971[5]
Mouradian et al, 1974[6]

31 y/F
49 y/F
23 y/F
26 y/F

BGCT
BGCT
BGCT
BGCT

Fletcher et al, 1985[7]

48 y/M

BGCT

No
No
(not stated)
Yes: at 10 and 17 months postop.
No

Well for 18 years
Well for 1 year
(course unknown)
Disease free after recurrences
for 2.5 years
(time period not stated)

Kontani et al, 1999[8]

59 y/F

BGCT

Complete Trans-urethral
resection
Segmental resection
Partial cystectomy
Complete Resection
Complete Trans-urethral
resection.
Trans-urethral resection +
suprapubic exploration and
drainage of perivesical space.
Complete TURBT

Died from recurrence +
metastases at 17 months
Well for 2 years

Anderson and Hoeg, 1968[2]

Yes: at 7 months post-op.

Yoshida et al, 2001[9]

48/M

BGCT

TURBT × 2

Disease free for 18 months
after 2nd surgery
Well for 3 1/2 yrs.

Present series
Present series

14/F
47/F

BGCT
MGCT

Complete TURBT
Radical cystectomy,
hysterectomy, bilateral salpingooophorectomy + pelvic node
dissection.

Yes: average 6 months. No
recurrence for 3 yrs after 2nd
TURBIT
No
No

NED for 4 years.
NED for 4 years.

*MGCT = Malignant granular cell tumor
** BGCT = Benign granular cell tumor

tumor extension or distant metastasis. A cystic left ovarian
mass was recognized, which later turned out to be benign
ovarian cyst with no malignancy. A planned radical cystectomy, bilateral salpingo-oophorectomy, hysterectomy,
ileal conduit and pelvic lymph node clearance with resection of the anterior wall of the vagina was carried out in
June 1995 realizing the malignant nature of the tumor.
She made an uneventful recovery and histopathology confirmed a pT3N0M0 malignant granular cell tumor of the
urinary bladder. She remains free of disease recurrence at
8 years since the operation.

Discussion
Granular cell tumor (GCT) is an extremely rare neoplasm
affecting the urinary bladder with only 9 cases described
so far (Table 1) [1-9]. Although the large majority follows
a clinically benign course, they are commonly mistaken
for malignant tumors at the outset, as they are usually
solid looking, ulcerated tumors with ill-defined margins.
The entity was originally described by Abrikosoff [10] in
1926 as originating from myoblasts, granular cell tumors
are now generally believed to have a neural (probably the
Schwann cell) precursor based on histochemical, immunohistochemical and ultrastructural findings [6,11].
However, in some lesions there is no evidence of Schwann
cell proliferation [12]. They occur more commonly at
other sites with 30–50% of cases reported in the head and
neck region [13]. The lesions can be multiple and multifocal. Middle-aged males are most commonly affected
though these tumors can occur in persons of all ages.

Depending on the site and size of these tumors, the
patients can present from asymptomatic nodules to symptoms due to pressure effects on vital structures such as the
trachea, esophagus and pituitary gland. Gross hematuria
is the most common symptom in patients affected with
granular cell tumor of the urinary bladder.
Histologically, Granular cell tumor of the urinary bladder
is indistinguishable from similar tumors occurring at
other sites. Immunohistochemical studies are particularly
useful to differentiate such tumors from carcinomas and
sarcomas as GCTs reveal positive staining for S-100 protein, calretinin, alpha subunit of inhibin HLA-DR, laminin and various myelin proteins [14]. The cells do not
react with antibodies for neurofilaments proteins or glial
fibrillary acidic protein [15,16]. Non reactivity to epithelial and muscle markers differentiates them from carcinomas and sarcomas [17]. Malignant granular cell tumors
tend to be larger, more rapidly growing, and located predominantly in the extremities when compared to the
smaller, benign granular cell tumors seen in the head and
neck regions. Most cases reported in old literature as
malignant granular cell myoblastomas were later
reviewed and were found to be alveolar sarcomas and
other malignancies [6].
Granular cells are not unique to granular cell tumors as
cytoplasmic granularity typical of GCT (both benign and
malignant) has been observed in neoplastic and in nonneoplastic conditions, such as ameliobiastoma [17],
amelioblastic fibroma [18,19], severed nerves undergoing
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Wallerian degeneration [20], traumatized muscle [21],
leiomyosarcoma [22], angiosarcoma and appendiceal
granular cell lesions.
GCT is rarely diagnosed prior to microscopic examination
of the biopsy or excised specimen and often is an incidental finding during routine physical examination. As a rule,
GCTs generally tend to follow a benign clinical course and
of the nine previously reported cases of GCT of the urinary
bladder, only one was malignant (Table 1). Conservative
surgical treatment such as transurethral resection alone or
partial cystectomy appears to offer adequate means of
local control for benign tumors and more radical resections are not required. It is crucial that these benign
tumors be clearly differentiated from much more common malignant solid tumors of the urinary bladder to
save the patient from radical management protocols. In
our first case, for instance, conservative surgical treatment
was adequate. Given the limited information, it appears
appropriate to recommended periodic follow up of these
cases to rule out recurrence.
Malignant GCT although well established is extremely
rare and poses a difficult diagnostic problem. Benign and
malignant GCT could be similar in histological appearance. Clinical features such as rapid growth, presence of
metastases and local recurrence generally indicates the
tumor to be malignant. Microscopic features that favor a
diagnosis of malignancy include cellular growth in sheets
and clusters with invasion, nuclear hyperchromasia, presence of necrosis, and pleomorphism. Malignant GCTs
tend to be slightly more cellular with smaller cells assuming spindle cell morphology. It has been noted that cellular variability or pleomorphism alone is not always a
reliable diagnostic criterion. Other features especially
when seen in combination such as necrosis, large vesicular nuclei with large nucleoli and high MIB-1 values favor
malignancy. There is also an appreciable mitotic rate,
although not apparent microscopically, 2 or more mitotic
figures10/HPF should raise the suspicion of malignancy
[14,17].

http://www.wjso.com/content/5/1/33

assessment for establishing the appropriate diagnosis and
either a conservative or aggressive surgical treatment for
benign or localized malignant GCT of the urinary bladder,
respectively.
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